NO20061758L - Hurtigtest for diagnose av Alzheimers sykdom - Google Patents

Hurtigtest for diagnose av Alzheimers sykdom

Info

Publication number
NO20061758L
NO20061758L NO20061758A NO20061758A NO20061758L NO 20061758 L NO20061758 L NO 20061758L NO 20061758 A NO20061758 A NO 20061758A NO 20061758 A NO20061758 A NO 20061758A NO 20061758 L NO20061758 L NO 20061758L
Authority
NO
Norway
Prior art keywords
disease
alzheimer
diagnosis
quick test
early stage
Prior art date
Application number
NO20061758A
Other languages
English (en)
Other versions
NO335704B1 (no
Inventor
Thomas Arendt
Jens Stieler
Original Assignee
Uni Leipzig
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uni Leipzig filed Critical Uni Leipzig
Publication of NO20061758L publication Critical patent/NO20061758L/no
Publication of NO335704B1 publication Critical patent/NO335704B1/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70514—CD4
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70517—CD8
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/7056—Selectin superfamily, e.g. LAM-1, GlyCAM, ELAM-1, PADGEM
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)

Abstract

Den foreliggende oppfinnelsen vedrører en fremgangsmåte for diagnostisering av Alzheimers sykdom, eller et tidlig stadium derav, eller predisponering for sykdommen. Fremgangsmåten er basert på kvanti fikasjon av mitogensk uttrykkbare overflatemarkører, fortrinnsvis CD69, og tilhørende periferisk tilgjengelige celler, for eksempel hudceller eller lymfocytter, (a) før og (b) etter mitogen stimulering. En spesiell stimuleringsindeks a b er et tegn på Alzheimers sykdom eller et tidlig stadium derav, eller predisponering for sykdommen. Den foreliggende oppfinnelsen vedrører også kitt passende for å utføre den diagnostiske fremgangsmåten i følge oppfinnelsen.
NO20061758A 2003-10-22 2006-04-20 Hurtigtest og kitt for diagnose av Alzheimers sykdom. NO335704B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10349162A DE10349162A1 (de) 2003-10-22 2003-10-22 Schnelltest zur Diagnose der Alzheimerschen Erkrankung
PCT/EP2004/010889 WO2005050219A1 (de) 2003-10-22 2004-09-29 Schnelltest zur diagnose der alzheimerschen erkrankung

Publications (2)

Publication Number Publication Date
NO20061758L true NO20061758L (no) 2006-07-06
NO335704B1 NO335704B1 (no) 2015-01-26

Family

ID=34529710

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20061758A NO335704B1 (no) 2003-10-22 2006-04-20 Hurtigtest og kitt for diagnose av Alzheimers sykdom.

Country Status (15)

Country Link
US (2) US20070218497A1 (no)
EP (1) EP1685408A1 (no)
JP (1) JP2007509331A (no)
KR (1) KR101138343B1 (no)
CN (1) CN1871519A (no)
AU (1) AU2004290789B2 (no)
BR (1) BRPI0415212A (no)
CA (1) CA2540841A1 (no)
DE (1) DE10349162A1 (no)
IL (1) IL175004A0 (no)
NO (1) NO335704B1 (no)
RS (2) RS20060255A (no)
RU (1) RU2426130C2 (no)
WO (1) WO2005050219A1 (no)
ZA (1) ZA200603178B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1876449A1 (en) * 2006-07-07 2008-01-09 Universität Leipzig Cell cycle-based blood test to diagnose Alzheimer's disease
EP2389582B1 (en) * 2009-01-20 2016-04-06 Cambridge Enterprise Limited Methods for predicting autoimmune disease risk
GB201212084D0 (en) * 2012-07-06 2012-08-22 Randox Lab Ltd Tropomyosin isoforms related to alzheimers disease and mild cognitive impairment
EP3011336A4 (en) * 2013-06-20 2017-01-04 Amarantus Bioscience Holdings Inc. Methods, systems, and composition related to neural disorders
CN106885909B (zh) * 2017-01-19 2018-11-20 上海市东方医院 一种用于早期诊断阿尔茨海默病的试剂盒
CN111373259A (zh) * 2017-03-06 2020-07-03 塔拉里斯治疗股份有限公司 测定治疗性细胞组合物的效力的方法和组合物
CA3144876A1 (en) * 2019-07-10 2021-01-14 Todos Medical Ltd. A biomarker for alzheimer's disease using blood samples from clinically diagnosed alzheimer's disease subjects
CN117210549A (zh) * 2023-08-29 2023-12-12 河络新图生物科技(上海)有限公司 检测人atp5d、cd69和cxcr4基因的物质及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19936035C2 (de) * 1999-07-30 2002-11-21 Univ Leipzig Lymphozytenproliferationstestkit
US20020081635A1 (en) * 2000-05-11 2002-06-27 Thomas Terry E. Novel antibody compositions for preparing enriched T cell preparations

Also Published As

Publication number Publication date
DE10349162A1 (de) 2005-06-02
US20150079609A1 (en) 2015-03-19
US20070218497A1 (en) 2007-09-20
CA2540841A1 (en) 2005-06-02
WO2005050219A1 (de) 2005-06-02
RS20060255A (en) 2008-09-29
JP2007509331A (ja) 2007-04-12
BRPI0415212A (pt) 2006-12-05
NO335704B1 (no) 2015-01-26
KR101138343B1 (ko) 2012-04-26
AU2004290789B2 (en) 2010-01-21
CN1871519A (zh) 2006-11-29
IL175004A0 (en) 2006-08-20
ZA200603178B (en) 2007-07-25
EP1685408A1 (de) 2006-08-02
KR20060100423A (ko) 2006-09-20
AU2004290789A1 (en) 2005-06-02
RU2006112203A (ru) 2007-11-27
RS52875B (en) 2013-12-31
RU2426130C2 (ru) 2011-08-10

Similar Documents

Publication Publication Date Title
NO20061758L (no) Hurtigtest for diagnose av Alzheimers sykdom
Baccino et al. Evaluation of seven methods of estimating age at death from mature human skeletal remains
ATE232620T1 (de) Reflexalgorithmus zur frühen und kostengünstigen diagnose von myokardischen infarkten geeignet für automatisierte diagnostische plattformen
WO2004090550A3 (en) A method for detection of colorectal cancer in human samples
ATE203329T1 (de) Verfahrens und testsätze zur diagnose periodentahlkrankheiten und zur vorhersage des risikos der progression davon
NO331148B1 (no) Anvendelse av et monoklonalt eller polyklonalt antistoff, samt fremgangsmate og kit for in vitro diagnose.
BR0301719A (pt) Processo para diagnosticar enfarte do miocárdio e/ou estratificação de risco da sìndrome aguda das coronárias, conjunto de reagentes para realizar esse diagnóstico e utilização do mesmo
BRPI9912227A (pt) método para diagnóstico precoce in vitro de carcinomas e de seus estágios iniciais e kit para realização do método.
DE69840154D1 (de) Verfahren zur Diagnose der Alzheimer Erkrankung auf der Basis eines Gen Transkriptionsmusters
ATE223051T1 (de) Verfahren zur diagnose gutartiger prostataerkrankungen
DK0756708T3 (da) Anvendelse af humant neutrophil-lipocalin (HNL) som en diagnostisk markør og anti-HNL-antistof-præparat
DE69531345D1 (de) Rekombinant pgp3, verfahren zu dessen herstellung, und dessen verwendung in der diagnose und therapie
NO982265L (no) Diagnostikk for og mediatorer for inflammatoriske forstyrrelser
WO2003046808A3 (en) Method for distinguishing benign and malignant nodules
ATE422671T1 (de) Verfahren zur diagnose von morbus alzheimer
HUP0003684A2 (hu) Alzheimer-kór diagnosztizálására szolgáló vizsgálat
DK0946874T3 (da) Diagnose af Helicobacter Pylori
BR0115131A (pt) Teste de urina para a diagnose de doenças de priÈnio
DE60038614D1 (de) Verfahren zur diagnose von synovialen oder osteoartikulären erkrankungen
ATE275268T1 (de) Verfahren zur diagnose von sjögren-syndrom
Vangel Normative Studies Research Project test battery: Detection of dementia in African American and European American urban elderly patients
Shewan et al. A comparison of three methods to evaluate change in the spontaneous language of aphasic individuals
DE69737863D1 (de) Immunologische zusammensetzung zum nachweis von blasenkrebs und verfahren zu ihrer verwendung
WO2003104812A3 (en) DIAGNOSIS ASSAY FOR ALZHEIMER'S DISEASE BASED ON THE DETERMINATION OF THE HA DOLLAR G (B) 42 RATE: HA DOLLAR G (B) 40
ATE459877T1 (de) Diagnostikum für die frühe phase von morbus alzheimer

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees